Grange Capital, LLC
- SEC CIK
- 0002048387
- Latest filing
- Jul 28, 2026
SLS holding history
SELLAS Life Sciences Group, Inc. in every 13F filed by Grange Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SLS overviewAll 13F holders of SLSFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −17,651−100.0% | Sold out | Holders |
| Q1 2026 | 17,651 | $74.7K | 0.1% | +1,650+10.3% | Added | Holders |
| Q4 2025 | 16,001 | $60.3K | 0.1% | +2,500+18.5% | Added | Holders |
| Q3 2025 | 13,501 | $21.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 13,501 | $29.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 13,501 | $14.6K | <0.1% | +13,501 | New | Holders |